Robin Foà

27PUBLICATIONS
120CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Adolescent healthLiquid biopsiesOrthopaedicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 14, 2026
Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

|Sep 08, 2026
Clinical Outcomes of Younger Adults With Philadelphia-Negative Acute Lymphoblastic Leukemia, Treated With A Pediatric-Like Regimen Based on the GIMEMA LAL1308 Protocol. A Campus ALL Study.

|Jan 22, 2026
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia.

Michela Ansuinelli, Nadia Peragine, Maria Stefania De Propris

|Jul 08, 2025
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma.

Riccardo Dondolin, Federico Garrou, Mohammad Almasri

|Jun 02, 2025
Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study.

Gianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni

|Dec 21, 2023
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.

Robin Foà, Renato Bassan, Loredana Elia

Pageof 5

Frequent Collaborators

6 joint publications

Massimiliano Bonifacio

4 joint publications

Federico Lussana

4 joint publications

Anna Candoni

4 joint publications

Sabina Chiaretti